Dow Jones Newswires: Ipsen to acquire U.S.-based Epizyme for $247 million.
The primary focus of the acquisition is the lead medicine, Tazverik, which was granted FDA accelerated approval in 2020
The primary focus of the acquisition is the lead medicine, Tazverik, which was granted FDA accelerated approval in 2020
The decision was based on trial results showing that Enhertu cut the risk of disease progression or death by 72% compared with the trastuzumab emtansine...
‘She is 33 years old, does not have a track record of holding down a steady job, and pays rent late in the month.’
Buying prescription meds from fraudulent online pharmacies can jeopardize your health and compromise your financial and personal data.
Fourth of July weekend is usually a good time to get a discount on a car, but this year, not so much. Here are some...
One small bright spot among the bleak outlook for summer travel costs: The U.S. dollar is especially strong against many foreign currencies.
There's lots of exciting new options in the EV market, but this veteran still gets the job done at the right price.
Small-business owners are also dealing with higher prices and supply chain problems. Here's where they're feeling it the most.
U.S. stock futures pointed to an extension of last week's gains, buoyed by data showing a slowing economy that in turn could limit the magnitude...